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Abstract
Rationale Crying is a unique human emotional reaction
that has not received much attention from researchers. Little
is known about its underlying neurobiological mechanisms,
although there is some indirect evidence suggesting the
involvement of central serotonin.
Objectives We examined the acute effects of the adminis-
tration of 20 mg paroxetine on the crying of young, healthy
females in response to emotional movies.
Methods We applied a double-blind, crossover randomised
design with 25 healthy young females as study participants.
On separate days, they received either paroxetine or
placebo and were exposed to one of two emotional movies:
‘Once Were Warriors’ and ‘Brian’s Song’. Crying was
assessed by self-report. In addition, the reactions to
emotional International Affective Picture System (IAPS)
pictures and mood were measured.
Results Paroxetine had a significant inhibitory effect on
crying. During both films, the paroxetine group cried
significantly less than the placebo group. In contrast, no
effects on mood and only minor effects on the reaction to
the IAPS pictures were observed.
Conclusions A single dose of paroxetine inhibits emotional
crying significantly. It is not sure what the underlying
mechanism is. However, since there was no effect on mood
and only minor effects on the response to emotional
pictures, we postulate that paroxetine mainly acts on the
physiological processes involved in the crying response.
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Introduction
Crying is a uniquely human emotional response. The utility of
crying for newborns, which seems functionally equivalent to
the so-called separation calls of offspring of birds and
mammals, is well established, but little is known about the
functions, determinants, and consequences of crying in adults
(Vingerhoets 2011; Vingerhoets et al. 2009). With respect to
individual differences, factors, such as age, sex, attachment
style, and personality (e.g., neuroticism and empathy), play a
role (Vingerhoets 2011), but little is known about the
underlying neurobiological mechanisms (Newman 2007).
Crying is considered as a behaviour that typically occurs
when attachment relations are broken and humans feel
helpless and in need of support of others (Vingerhoets 2011).
Pathological crying, a condition frequently observed
among neurological patients, can be successfully treated
with selective serotonin reuptake inhibitors (SSRIs), sug-
gesting that serotonin may modulate crying (Muller et al.
1999). Furthermore, studies have shown that tryptophan,
which is the precursor of 5-HT, is reduced in women in the
postpartum period (Maes et al. 2001), which is character-
ised by emotional lability and a high-crying proneness
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(Bailara et al. 2006). Finally, preliminary data suggest that
being in love is accompanied by low 5-HT levels (Marazziti et
al. 1999) and a greater crying proneness (Vingerhoets and van
Assen 2009). Together, this evidence suggests that central 5-
HT levels might increase the threshold for crying. Therefore,
we directly examined whether acute increases in central 5-HT
levels by means of the SSRI paroxetine increases the crying
threshold. To test this hypothesis, we designed a study in
which participants watched two emotional movies on two
different days and had to self-report their crying behaviour.
On one day, the participants received paroxetine, and on the
other day, they received placebo. It was hypothesised that self-
reported crying would be reduced on the paroxetine day.
Because there are some inconsistent findings suggesting that
that SSRIs might influence the appraisal of emotional stimuli
(Bruhl et al. 2010; Takahashi et al. 2005), we additionally
examined the effect of paroxetine on the appraisal of
emotional pictures. In this way, we could relate changes in
crying behaviour to the possible effects on the appraisal of
emotional stimuli and subsequent emotions which might
underlie changes in emotional expression. Finally, we
measured mood to examine whether preexisting mood or
paroxetine induced mood changes were related to changes in
crying behaviour. No direct effects on mood were expected.
Method
Participants
Participants were 25 healthy, young females recruited bymeans
of advertisements. Inclusion criteria were: healthy females, free
of medication (except for oral contraceptives) in the age-range
of 18–27 years (mean=21.4; standard error of mean=0.4). The
main reason to focus on young women is that we wanted to
prevent floor effects. It is known that women in the fertile age
range cry most frequently and we therefore expected to have
the highest chance to measure an effect if we included only
young women. Exclusion criteria were current somatic,
neurological, and psychiatric disturbances and insufficient
knowledge of the Dutch language to complete the question-
naires and mood self-reports. Health was checked with a short
interview combined with a custom-made questionnaire. Partic-
ipants were paid €100 for their participation. The study was
approved by the Medical Ethics Committee of the Erasmus
Medical Centre, Rotterdam, where this study was performed,
and participants provided written informed consent.
Design
We applied a double-blind randomised placebo-controlled
single-dose crossover design. Fifteen participants received
20 mg paroxetine on the first day, and the other ten
participants were administered paroxetine on the second
day. Determination of the dosage was based on the usual
dosage given to depressed patients and to allow comparability
with other studies studying the effects of 5-HT on cognition
and emotion using paroxetine (de Bruijn et al. 2006). In
addition, it is known that 20 mg paroxetine yields the
maximal effect on central 5-HT levels, because of a maximal
occupancy of the 5-HT transporter (Ruhe et al. 2009).
Procedure
Participants arrived between 9.00 and 10.00 h in the laboratory
and were tested in a group of either 12 or 13 participants. The
group of 12 participants watched ‘Brian’s Song’ on the first day
and ‘OnceWereWarriors’ a week later, whereas the group of 13
participants watched themovies in the opposite order. Paroxetine
and placebo, in the form of tablets, were administered orally.
After administration of paroxetine or placebo, several question-
naires (see below) were completed. After a 5-h waiting period,
which was implemented to achieve a maximal effect on central
5-HT levels (Kaye et al. 1989), participants first completed a
mood questionnaire and subsequently watched the movie. After
the movie, participants completed the crying questionnaire and
judged emotional pictures (see below).
Movies
We used two emotional movies, i.e., ‘Brian’s Song’ and ‘Once
Were Warriors’, to induce crying behaviour. Both movies were
successfully used in previous crying research by our research
group. No specific instructions were given for watching the
movie. We assessed crying behaviour by means of self-report.
The outcome measure is the level of crying varying from 0 (no
emotion) to 6 (teary eyes, sobbing, loud crying, body motions,
and yelling), during a number of predetermined dramatic scenes.
Questionnaires
Mood was assessed at the beginning of the session and
immediately before exposure to the movie on both days,
using a visual analogue version of the profiles of mood
scale (McNair et al. 1992).
Emotional pictures
Emotional pictures were derived from the International
Affective Picture System (IAPS; Lang et al. 2005). Forty
pictures were selected based on their standard norm scores.
Ten pictures with a low-pleasure and low-arousal scores,
ten pictures with a low-pleasure and high-arousal score, ten
pictures with a high-pleasure and low-arousal score, and ten
pictures with a high-pleasure and a high-arousal score were
selected. Twenty of these pictures were used for the first
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session, and 20 were used for the second session; the order
was balanced between subjects. Both sets of pictures thus
consisted of five pictures of each of the four different
stimulus categories. Pictures were projected on a screen for
6 s each. Each picture was immediately rated in terms of
arousal and valence by means of the standardised self-
assessment manikin (Lang 1980). After the rating was
completed, the next picture was presented.
Statistical analysis
Ratings and mood were analysed using SPSS 16 for Windows.
Subjective rating of crying behaviour was tested with a general
linear model (GLM) for repeated-measures analysis with
treatment (two levels; paroxetine vs. placebo) as within-
subjects factor and treatment order (two levels; paroxetine or
placebo first) and movie order (two levels; ‘Brian’s Song’ first
or ‘Once Were Warriors’ first) as between-subjects factors.
Average arousal and valence ratings were tested separately
using a simple model with treatment (two levels; paroxetine vs.
placebo) as within-subjects factor. We additionally evaluated
the ratings for the subcategories of pictures in detail with
arousal category (two levels; high arousal vs. low arousal),
valence category (two levels; high pleasure vs. low pleasure)
and treatment as within-subjects factors. Average subjective
mood ratings as measured with the POMS were tested
separately for the five subscales (anger, fatigue, depression,
vigor, and tension) in a model with time (two levels; before or
after movie) and treatment as within-subjects factor.
Table 1 lists the mean and standard error of mean scores
of subjective ratings of the four categories of emotional
pictures in subjects given paroxetine and placebo.
Results
Crying behaviour
Analysis of variance showed that paroxetine strongly
affected the intensity of self-reported crying behaviour
(main effect treatment, F1,21=16.9, P<0.0005, η
2=0.45; see
Fig. 1). For ‘Brian’s Song’, mean z-score was −0.41±0.29
(mean±standard error of the mean) on the paroxetine day
vs. 0.38±0.24 on the placebo day. For ‘Once Were
Warriors’, mean z-scores were −0.47±0.16 on the parox-
etine day vs. 0.51±0.33 on the placebo day. In addition, an
interaction between treatment and movie order was found:
F1,21=6.1, P<0.05, η
2=0.23. Follow-up analyses showed
that for the participants who saw ‘Brian’s Song’ in the first
session, the effect of treatment was stronger (P<0.001, one-
sided) and only marginally significant (P=0.051, one-
sided) for the opposite order (effect was in the same
direction). The effect of treatment order did not interact
with any of these effects.
Emotional pictures
In a first analysis, the average rating of all pictures in terms
of arousal and valence was tested. No significant effects of
paroxetine were found. In a second, more detailed, analysis,
arousal and pleasure ratings of specific categories of the
emotional pictures were evaluated with treatment, valence
category and arousal category as within-subjects factors. In
this analysis, we found, for arousal ratings, main effects of
arousal category, F1,24=50.6, P<0.0005, η
2=0.68, and
valence category, F1,24=31.9, P<0.0005, η
2=0.57, and
two-way interactions between treatment and arousal cate-
gory, F1,24=4.3, P<0.05, η
2=0.15 and arousal and valence
category, F1,24=9.8, P<0.0005, η
2=0.41. As expected,
pictures in the high-arousal category were rated as more
arousing, and this effect was stronger for low-pleasure
pictures. Treatment interacted with arousal ratings in
different categories and follow-up paired t-tests showed
that paroxetine only significantly decreased arousal ratings
in the high-arousal/low-valence category.
For the pleasure ratings, we found main effects of
arousal category, F1,24=30.3, P<0.0005, η
2=0.56, and
valence category, F1,24=151.7, P<0.0005, η
2=0.86, and
two-way interactions between treatment and valence cate-
gory, F1,24=6.0, P<0.05, η
2=0.20 and arousal and valence
Table 1 Mean and standard error of mean scores of the subjective ratings (arousal/pleasure) of the four categories of emotional pictures (high/low
arousal, high/low pleasure) on the paroxetine and the placebo day
Self-assessment manikin (SAM) High pleasure Low pleasure
High arousal Low arousal High arousal Low arousal
Arousal Paroxetine 2.7 (.34) 1.7 (.17) 3.6 (.42)* 2.1 (.21)
Placebo 2.8 (.13) 1.7 (.13) 4.4 (.34) 2.2 (.23)
Pleasure Paroxetine 6.4 (.18)* 6.1 (.17) 3.1 (.23) 4.7 (.14)
Placebo 6.8 (.15) 6.0 (.17) 2.7 (.19) 4.4 (.16)
* Significant difference between paroxetine and placebo day (P<0.05)
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category, F1,24=80.1, P<0.0005, η
2=0.77. As anticipated,
pleasure ratings were higher for the high-pleasure pictures,
and this effect was stronger for pictures in the high-arousal
category. Treatment interacted with pleasure ratings in
different categories and follow-up paired t-tests showed
that paroxetine only significantly decreased pleasure ratings
in the high-arousal/high-valence category.
Given the treatment effect on arousal and pleasure
ratings, one may wonder whether the altered appraisal of
some emotional stimuli could be responsible for the
reduced crying response to the movies, as observed in the
paroxetine condition. To examine this, correlations between
the picture ratings and crying were computed. This revealed
a significantly positive correlation between the arousal
score for the high-arousal/low-pleasure category in the
paroxetine condition and crying (r=0.52, P<0.01). In
contrast, the valence scores in the high-pleasure/high-
arousal category did not show an association with crying.
To summarise, paroxetine did not influence overall ratings
of emotional pictures, but only in specific categories of
pictures arousal and pleasure ratings were slightly lowered
by paroxetine. The association between arousal scores and
crying suggests a possible partly shared underlying process.
Mood
Mood was not affected by treatment or time. For none of
the five subscales, significant main effects of treatment,
time, or interactions between these two factors were found
(all P values>0.15).
Discussion
The main finding of the present study is that paroxetine
reduces crying which clearly supports our hypothesis that 5-
HT is involved in crying. However, we are not yet certain
about the underlyingmechanism, since we found evidence that
this effect, at least partially, can be attributed to the changed
appraisal of emotional stimuli. Although only the arousal
ratings of one subset of pictures and the pleasure ratings of
another subset of pictures was affected, the effects were in the
expected direction and especially the category of pictures, in
which the arousal scores were affected, was most comparable
to the movie scenes in terms of emotional content. In addition,
arousal ratings were associated with crying behaviour only on
the paroxetine day. This association suggests that a common
process underlying both the crying in response to the movies
and the appraisal of the pictures might be affected. One
explanation is that the effect of paroxetine on crying was
caused by reduced recognition of emotional film stimuli
inducing the crying behaviour. However, this seems to be
contradicted by earlier findings demonstrating that acute
administration of a different SSRI (citalopram) enhanced
recognition of fearful and happy facial expressions while
leaving recognition of other emotional expressions intact
(Harmer et al. 2003). A second possibility is that emotional
impact of both the emotional film scenes and the emotional
pictures is lowered by paroxetine. Recent neuroimaging
findings support this notion. Citalopram decreased the
amygdala response to aversive stimuli (Anderson et al.
2007) and fearful facial expressions (Murphy et al. 2009).
This support, however, is indirect; moreover, the amygdala
has been associated with both emotional expression (e.g.,
affective startle modulation; Angrilli et al. 1996) and
evaluation of emotional stimuli. Finally, it should also be
noted that the effects of paroxetine on arousal and pleasure
ratings of the IAPS pictures in this study were small and the
correlation with crying behaviour was modest, which
suggests that the effect of paroxetine on crying behaviour is
most likely not caused by a changed appraisal of emotional
stimuli, but rather by its influence on other processes.
At first sight, the present effect of paroxetine on the
evaluation of emotional pictures does not seem compatible
with the results of previous studies (Bruhl et al. 2010;
Takahashi et al. 2005), which failed to show an effect of
different SSRIs on valence ratings of emotional pictures. It
should be noted, however, that these studies failed to
differentiate between subcategories of pictures in terms of
arousal and that, in the present study, these effects only
became manifest after differentiating. The effect of reduced
arousal scores for high-arousal pictures and lower-valence
scores for high-valence pictures suggests a blunting of
affectivity, an established side effect of SSRIs (Opbroek et
al. 2002; Price et al. 2009). A recent study (McCabe et al.
2010) further showed that the neuronal response to both
aversive and rewarding stimuli was reduced after 1-week
treatment with citalopram. However, the effects in the present
study were acute and selective for specific categories of
emotional pictures and therefore hard to compare with the
more long-term and general effects of the McCabe et al. study.
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Fig. 1 Effect of paroxetine or placebo on subjective crying as
expressed in z-scores (±standard error of the mean) for ‘Once Were
Warriors’ (warriors) and ‘Brian’s Song’ (Brian)
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The effect of paroxetine on crying as an emotional
expression seemed to contradict the results of other studies
examining other emotional expressions in mice (Gomes et
al. 2009) and humans (Grillon et al. 2007). More precisely,
Grillon et al. showed that a single dose of citalopram
facilitated the expression of fear in terms of an enhanced
potentiating of a startle response, and Gomes et al. showed
that acute effects of another SSRI (fluoxetine) increased
anxiety-related behaviour. The differences between the
specific SSRI used in the present and previous studies and
the different doses used can possibly explain the somewhat
inconsistent results in the various studies. Another possible
explanation for these different effects could be the strong
differences between the emotions involved in crying and
the expression of fear. Fear is more directly involved in
behaviour related to survival (fight/flight) and, in this way,
is directly linked to action. The emotions involved in crying
are not directly linked to action and are more related to
passive, inactive states. Therefore, serotonin might not have
an overall effect on emotional expressions, but might have
differential effects on expressions with different functions.
Crying is an emotional expression which can occur as the
result of experiencing several different emotions. Tears of
joy and sadness are clearly different, and, in this study, we
examined crying behaviour as the result of two quite
different movies. In one movie, crying behaviour is mostly
caused by feelings of empathic sadness (Brian’s Song) due
to the sad and hopeless situation of the main character. In
the second movie, emotions are more raw and violent and
crying behaviour is mostly caused by feelings of an angry,
horrified, or shocked type of sadness.
Since the relation between 5-HT and crying behav-
iour is not studied very extensively thus far, and precise
relations with underlying emotions and different types
of crying are unknown, the present study can be seen as
a first starting point and the interesting results ask for
further exploration concerning the effects of psycho-
pharmacological agents on different types of crying and
the underlying mechanisms.
Although the results are relatively clear and strong, the
study has some limitations. First, the number of tested
participants is relatively small, and we only tested female
volunteers without controlling the hormonal cycle and use
of oral contraceptives. Second, the number of used
emotional pictures to measure changes in emotional
appraisal was relatively small, and the present study only
used subjective measures to quantify crying behaviour.
Finally, although paroxetine is an SSRI, it might have
affected other neurotransmitter systems directly or indirect-
ly, and the reported effects therefore might have been at
least partially caused by nonserotonergic mechanisms.
Future studies should use more objective measures to
quantify crying behaviour, aim to include a larger sample
of volunteers, control hormonal status, and use more
selective serotonergic manipulations.
In conclusion, this is the first study that shows a direct
relation between central 5-HT levels and crying behaviour
in healthy volunteers. It demonstrates that SSRIs have a
major inhibitory effect on crying, which can have serious
consequences for both the measured and experienced
treatment effects of SSRIs. Further research is necessary
to show whether the role of 5-HT is restricted to crying
behaviour or whether it extends to other emotional expres-
sions as well (e.g., smiling, laughing; see Mergl et al. 2003).In
addition, the effects of SSRIs on the appraisal of emotional
stimuli needs further clarification, with adequate attention for
qualitatively different emotions. Future research should also
focus on the possible effects of SSRIs on so-called
sentimental or ‘positive’ crying, typically induced by movies
depicting themes like self-sacrifice or altruism. Taken
together, this would lead to a better insight into the
underlying neurobiological mechanisms of this mysterious
and important, but scientifically ignored and poorly under-
stood human behaviour.
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